DNA-based diagnosis of the von Hippel-Lindau syndrome.

Abstract

PURPOSE To evaluate the etiology of a unilateral hemangioblastoma noted in a male with a family history remarkable only for spine surgery in the proband's father. METHODS Genomic DNA was isolated from peripheral blood of family members, and the three exons of the von Hippel-Lindau gene were examined for mutations by direct sequencing. RESULTS A three base pair (bp) deletion in exon 1 of the VHL gene was found in the father and both sons. This in-frame deletion results in the loss of a phenylalanine residue from the von Hippel-Lindau protein product, at amino acid position 76. CONCLUSION Genetic screening has confirmed that von Hippel-Lindau syndrome is responsible for the hemangioblastoma in the proband. Magnetic resonance imaging scans performed as a consequence of these results indicated spinal tumors present in the father and tumors present in the cerebellum of the proband's sibling. As close, lifelong follow-up is warranted with this disease, this case demonstrates the value of DNA testing in patients with ocular findings consistent with von Hippel-Lindau disease in the absence of a recognized family history.

Statistics

0200400'01'03'05'07'09'11'13'15'17
Citations per Year

143 Citations

Semantic Scholar estimates that this publication has 143 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Patel2000DNAbasedDO, title={DNA-based diagnosis of the von Hippel-Lindau syndrome.}, author={Ronak J. Patel and Binoy Appukuttan and Sandra H. Ott and X Wang and Julie C. Stout}, journal={American journal of ophthalmology}, year={2000}, volume={129 2}, pages={258-60} }